Phibro Animal Health (PAHC) Cash from Investing Activities Growth (3y) (2016 - 2026)
Powered by 
Analysis
Phibro Animal Health (PAHC) Cash from Investing Activities Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.51 Bn | 40.32 Bn | 779.09 Mn | 2.46% |
| 2 | Zoetis | 30.62 Bn | 28.94 Bn | 1.05 Bn | -55.36% |
| 3 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | -36.76% |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn | -16.96% |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 74.81 Mn | 67.72 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -16.96% |
| Mar 31, 2026 | 23.66% |
| Dec 31, 2025 | -20.55% |
| Sep 30, 2025 | -9.17% |
| Jun 30, 2025 | 9.66% |
| Mar 31, 2025 | -22.44% |
| Dec 31, 2024 | -156.25% |
| Sep 30, 2024 | 47.86% |
| Jun 30, 2024 | -8.21% |
| Mar 31, 2024 | -51.44% |
| Dec 31, 2023 | -48.29% |
| Sep 30, 2023 | -4.03% |
| Jun 30, 2023 | -2.55% |
| Mar 31, 2023 | -38.73% |
| Dec 31, 2022 | 34.04% |
| Sep 30, 2022 | 36.32% |
| Jun 30, 2022 | -38.33% |
| Mar 31, 2022 | -7.75% |
| Dec 31, 2021 | 78.38% |
| Sep 30, 2021 | -8.57% |